Insight into the medicinal chemistry of the endocannabinoid hydrolase inhibitors.
Curr Med Chem 2014;
20:1824-46. [PMID:
23410152 DOI:
10.2174/09298673113209990108]
[Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2012] [Revised: 01/07/2013] [Accepted: 02/13/2013] [Indexed: 11/22/2022]
Abstract
Endocannabinoid hydrolases are nowadays increasingly considered as potential therapeutic targets for treating several pathological states. So far, numerous classes of endocannabinoid hydrolase inhibitors have been described. We herein review the medicinal chemistry of these inhibitors with a particular emphasis on the basis of their design, chemical structure, structure-activity relationships, and inhibition mechanisms.
Collapse